Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction†

被引:194
作者
Huikuri, Heikki V. [1 ]
Raatikainen, M. J. Pekka [1 ]
Moerch-Joergensen, Rikke [2 ]
Hartikainen, Juha [3 ]
Virtanen, Vesa [4 ]
Boland, Jean [5 ]
Anttonen, Olli [6 ]
Hoest, Nis [7 ]
Boersma, Lucas V. A. [8 ]
Platou, Eivind S. [9 ]
Messier, Marc D. [10 ]
Bloch-Thomsen, Poul-Erik [2 ]
机构
[1] Univ Oulu, Dept Internal Med, Oulu 90014, Finland
[2] Gentofte Univ Hosp, Copenhagen, Denmark
[3] Univ Kuopio, Dept Internal Med, FIN-70211 Kuopio, Finland
[4] Univ Tampere, Dept Cardiol, FIN-33101 Tampere, Finland
[5] Hop Citadelle, Dept Internal Med, Liege, Belgium
[6] Paijat Hame Cent Hosp, Dept Internal Med, Lahti, Finland
[7] Glostrup Cty Hosp, Copenhagen, Denmark
[8] St Antonius Hosp, Nieuwegein, Netherlands
[9] Ullevaal Univ Hosp, Dept Cardiol, Ctr Arrhythmias, Oslo, Norway
[10] Medtron Bakken Res Ctr, Maastricht, Netherlands
关键词
Sudden cardiac death; Heart rate; Variability; Implantable cardioverter-defibrillator; T-WAVE ALTERNANS; HEART-RATE-VARIABILITY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; RISK STRATIFICATION; SUDDEN-DEATH; MORTALITY; DYSFUNCTION; TRIAL; TACHYCARDIA; EJECTION;
D O I
10.1093/eurheartj/ehn537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine whether risk stratification tests can predict serious arrhythmic events after acute myocardial infarction (AMI) in patients with reduced left ventricular ejection fraction (LVEF <= 0.40). A total of 5869 consecutive patients were screened in 10 European centres, and 312 patients (age 65 +/- 11 years) with a mean LVEF of 31 +/- 6% were included in the study. Heart rate variability/turbulence, ambient arrhythmias, signal-averaged electrocardiogram (SAECG), T-wave alternans, and programmed electrical stimulation (PES) were performed 6 weeks after AMI. The primary endpoint was ECG-documented ventricular fibrillation or symptomatic sustained ventricular tachycardia (VT). To document these arrhythmic events, the patients received an implantable ECG loop-recorder. There were 25 primary endpoints (8.0%) during the follow-up of 2 years. The strongest predictors of primary endpoint were measures of heart rate variability, e.g. hazard ratio (HR) for reduced very-low frequency component (< 5.7 ln ms(2)) adjusted for clinical variables was 7.0 (95% CI: 2.4-20.3, P < 0.001). Induction of sustained monomorphic VT during PES (adjusted HR = 4.8, 95% CI, 1.7-13.4, P = 0.003) also predicted the primary endpoint. Fatal or near-fatal arrhythmias can be predicted by many risk stratification methods, especially by heart rate variability, in patients with reduced LVEF after AMI.
引用
收藏
页码:689 / 698
页数:10
相关论文
共 31 条
[1]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[2]   Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction:: cohort study [J].
Bauer, Axel ;
Kantelhardt, Jan W. ;
Barthel, Petra ;
Schneider, Raphael ;
Makikallio, Timo ;
Ulm, Kurt ;
Hnatkova, Katerina ;
Schornig, Albert ;
Huikuri, Heikki ;
Bunde, Armin ;
Malik, Marek ;
Schmidt, Georg .
LANCET, 2006, 367 (9523) :1674-1681
[3]   THE RELATIONSHIPS AMONG VENTRICULAR ARRHYTHMIAS, LEFT-VENTRICULAR DYSFUNCTION, AND MORTALITY IN THE 2 YEARS AFTER MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
KLEIGER, R ;
MILLER, JP ;
ROLNITZKY, LM .
CIRCULATION, 1984, 69 (02) :250-258
[4]   Mortality in patients after a recent myocardial infarction - A randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification [J].
Camm, AJ ;
Pratt, CM ;
Schwartz, PJ ;
Al-Khalidi, HR ;
Spyt, MJ ;
Holroyde, MJ ;
Karam, R ;
Sonnenblick, EH ;
Brum, JMG .
CIRCULATION, 2004, 109 (08) :990-996
[5]   Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) Trial [J].
Chow, Theodore ;
Kereiakes, Dean J. ;
Onufer, John ;
Woelfel, Alan ;
Gursoy, Sinan ;
Peterson, Brett J. ;
Brown, Mark L. ;
Pu, Wenji ;
Benditt, David G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (20) :1607-1615
[6]   Classification of death in antiarrhythmia trials [J].
Epstein, AE ;
Carlson, MD ;
Fogoros, RN ;
Higgins, SL ;
Venditti, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) :433-442
[7]   Noninvasive risk assessment early after a myocardial infarction [J].
Exner, Derek V. ;
Kavanagh, Katherine M. ;
Slawnych, Michael P. ;
Mitchell, L. Brent ;
Ramadan, Darlene ;
Aggarwal, Sandeep G. ;
Noullett, Catherine ;
Van Schaik, Allie ;
Mitchell, Ryan T. ;
Shibata, Mariko A. ;
Gulamhussein, Sajad ;
McMeekin, James ;
Tymchak, Wayne ;
Schnell, Gregory ;
Gillis, Anne M. ;
Sheldon, Robert S. ;
Fick, Gordon H. ;
Duff, Henry J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (24) :2275-2284
[8]   Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events - A meta-analysis [J].
Gehi, AK ;
Stein, RH ;
Metz, LD ;
Gomes, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :75-82
[9]   Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction [J].
Gomes, JA ;
Cain, ME ;
Buxton, AE ;
Josephson, ME ;
Lee, KL ;
Hafley, GE .
CIRCULATION, 2001, 104 (04) :436-441
[10]   T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation [J].
Hohnloser, SH ;
Ikeda, T ;
Bloomfield, DM ;
Dabbous, OH ;
Cohen, RJ .
LANCET, 2003, 362 (9378) :125-126